Edarbi tablets (azilsartan medoxomil) for the treatment of high blood pressure (hypertension) in adults has been approved by the Food and Drug Administration (FDA), USA. The FDA says it approved Edarbi after examining data from clinical studies which clearly demonstrated Edarbi's superior efficacy compared to two already FDA-approved medications - Benicar (olmesartan) and Diovan (valsartan ...

The U.S. Food and Drug Administration approved Edarbi tablets (azilsartan medoxomil) to treat high blood pressure (hypertension) in adults. Data from clinical studies showed Edarbi to be more effective in lowering 24-hour blood pressure compared with two other FDA-approved hypertension drugs, Diovan (valsartan) and Benicar (olmesartan). "High blood pressure is often called the 'silent killer ...

DEERFIELD, Ill. and OSAKA, Japan, Feb. 25, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved EDARBI (azilsartan medoxomil) for the treatment of hypertension, or high blood pressure, in adults. EDARBI is an angiotensin II receptor ...

Title: Half of Adults Have Hypertension or High Cholesterol: CDC Category: Health News Created: 2/1/2011 8:05:00 PM Last Editorial Review: 2/2/2011

ATLANTA, Feb. 2 (UPI) -- Most U.S. adults with uncontrolled blood pressure or high cholesterol have health insurance and access to low-cost effective treatment, health officials say.